MoneyWorks4Me

Piramal Pharma gets EIR with VAI for USA manufacturing facility

13 Apr 2026 Evaluate

Piramal Pharma has received Establishment Inspection Report (EIR) with Voluntary Action Indicated (VAI) from U.S. Food and Drug Administration (USFDA) for its manufacturing facility located at Lexington, (Kentucky, USA). The receipt of said EIR marks successful closure of the inspection. 

Piramal Pharma provides end-to-end pharma services to customers and a portfolio of differentiated pharma products across a domestic and global distribution network.

Peers
Company Name CMP
Sun Pharma. Inds. 1846.80
Dr. Reddys Labs. 1228.60
Cipla 1390.60
Lupin 2069.80
Zydus Lifesciences 1216.00
View more..